Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Clinical trial NCT07270601 · RECRUITING

Trial details

NCT number: NCT07270601
Sponsor: ContextVision AB
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease NAFLD - Non-Alcoholic Fatty Liver Disease

Start date: 2025-11-17
Primary completion: 2026-10-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.